Mineralys Therapeutics, Inc. (MLYS)

Mineralys Therapeutics Statistics

Total Valuation

MLYS has a market cap or net worth of $2.87 billion. The enterprise value is $2.28 billion.

Market Cap	2.87B
Enterprise Value	2.28B

Important Dates

The next estimated earnings date is Wednesday, February 11, 2026, before market open.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

MLYS has 79.14 million shares outstanding. The number of shares has increased by 29.86% in one year.

Current Share Class	79.14M
Shares Outstanding	79.14M
Shares Change (YoY)	+29.86%
Shares Change (QoQ)	+7.86%
Owned by Insiders (%)	0.94%
Owned by Institutions (%)	78.60%
Float	56.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.97
P/TBV Ratio	4.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 25.50

Current Ratio	25.50
Quick Ratio	25.24
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -42.14% and return on invested capital (ROIC) is -28.29%.

Return on Equity (ROE)	-42.14%
Return on Assets (ROA)	-26.50%
Return on Invested Capital (ROIC)	-28.29%
Return on Capital Employed (ROCE)	-31.94%
Revenue Per Employee	n/a
Profits Per Employee	-$3.36M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +189.86% in the last 52 weeks. The beta is 0.40, so MLYS's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	+189.86%
50-Day Moving Average	39.87
200-Day Moving Average	25.05
Relative Strength Index (RSI)	40.87
Average Volume (20 Days)	1,495,424

Short Selling Information

The latest short interest is 7.95 million, so 10.04% of the outstanding shares have been sold short.

Short Interest	7.95M
Short Previous Month	7.41M
Short % of Shares Out	10.04%
Short % of Float	13.97%
Short Ratio (days to cover)	5.43

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-184.09M
Pretax Income	-171.36M
Net Income	-171.36M
EBITDA	-184.03M
EBIT	-184.09M
Earnings Per Share (EPS)	-$2.86

Balance Sheet

The company has $593.63 million in cash and n/a in debt, giving a net cash position of $593.63 million or $7.50 per share.

Cash & Cash Equivalents	593.63M
Total Debt	n/a
Net Cash	593.63M
Net Cash Per Share	$7.50
Equity (Book Value)	576.43M
Book Value Per Share	7.30
Working Capital	576.28M

Cash Flow

Operating Cash Flow	-171.37M
Capital Expenditures	n/a
Free Cash Flow	-171.37M
FCF Per Share	-$2.17

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MLYS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.86%
Shareholder Yield	-29.86%
Earnings Yield	-5.97%
FCF Yield	-5.97%

Analyst Forecast

The average price target for MLYS is $47.33, which is 30.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$47.33
Price Target Difference	30.42%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1